At this year's American Diabetes Association meeting in Orlando from June 22 to June 26, the hype was all about integrated technologies and convergence of data that could allow clinicians and their patients better monitor and manage diabetes care.
Insulet Corp., one of the smaller players in the highly competitive and lucrative diabetes market, hoped to gain attending physicians' attention with positive clinical study results of its Omnipod...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?